Fox Chase Cancer Center.
Oncology Nursing Society.
Oncol Nurs Forum. 2020 Nov 1;47(6):671-691. doi: 10.1188/20.ONF.671-691.
This evidence-based guideline intends to support clinicians, patients, and others in decisions regarding the treatment of constipation in patients with cancer.
An interprofessional panel of healthcare professionals with patient representation prioritized clinical questions and patient outcomes for the management of cancer-related constipation. Systematic reviews of the literature were conducted. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach was used to assess the evidence and make recommendations.
The panel agreed on 13 recommendations for the management of opioid-induced and non-opioid-related constipation in patients with cancer.
The panel conditionally recommended a bowel regimen in addition to lifestyle education as first-line treatment for constipation. For patients starting opioids, the panel suggests a bowel regimen as prophylaxis. Pharmaceutical interventions are available and recommended if a bowel regimen has failed. Acupuncture and electroacupuncture for non-opioid-related constipation are recommended in the context of a clinical trial.
SUPPLEMENTARY MATERIAL CAN BE FOUND AT HTTPS: //bit.ly/30y29sI.
本循证指南旨在为临床医生、患者和其他相关人员提供支持,帮助他们做出癌症相关便秘患者治疗决策。
具有患者代表的跨专业医疗保健专业人员小组优先考虑了癌症相关性便秘管理的临床问题和患者结局。对文献进行了系统评价。使用 GRADE(推荐评估、制定与评价)方法评估证据并提出建议。
专家组就癌症患者中阿片类药物引起的和非阿片类药物相关的便秘的管理达成了 13 项建议。
专家组有条件地建议在生活方式教育之外,采用肠道方案作为便秘的一线治疗方法。对于开始使用阿片类药物的患者,专家组建议使用肠道方案作为预防措施。如果肠道方案失败,可使用并推荐药物干预措施。在临床试验背景下,推荐非阿片类药物相关便秘的针灸和电针治疗。